{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:07:38Z","timestamp":1748246858878,"version":"3.37.3"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-Entry\/24\/2015"],"award-info":[{"award-number":["BT\/RLF\/Re-Entry\/24\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EEQ\/2020\/000299","ECR\/2017\/000235","3\/1\/1(22)\/2022-NCD-1"],"award-info":[{"award-number":["EEQ\/2020\/000299","ECR\/2017\/000235","3\/1\/1(22)\/2022-NCD-1"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-0714","ITR\/Adhoc\/18\/2020"],"award-info":[{"award-number":["IIRP-2023-0714","ITR\/Adhoc\/18\/2020"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.thromres.2024.04.026","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T08:52:38Z","timestamp":1714467158000},"page":"117-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial reperfusion injury"],"prefix":"10.1016","volume":"238","author":[{"given":"Moh","family":"Uzair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chahak","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangam","family":"Rajak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swasti","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanu","family":"Pande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.04.026_bb0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.04.026_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.04.026_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1089253211436350","article-title":"Myocardial ischemia reperfusion injury - from basic science to clinical bedside","volume":"16","author":"Frank","year":"2012","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.thromres.2024.04.026_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.115.305873","article-title":"Inhibition of platelet GPVI protects against myocardial ischemia-reperfusion injury","volume":"36","author":"Pachel","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0025","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2012-06-440255","article-title":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.04.026_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/SHK.0b013e31802fa038","article-title":"The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion","volume":"27","author":"Zacharowski","year":"2007","journal-title":"Shock Augusta Ga"},{"key":"10.1016\/j.thromres.2024.04.026_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1536\/ihj.14-322","article-title":"Platelet glycoprotein IIb\/IIIa inhibitor tirofiban ameliorates cardiac reperfusion injury","volume":"56","author":"Chang","year":"2015","journal-title":"Int. Heart J."},{"key":"10.1016\/j.thromres.2024.04.026_bb0045","first-page":"110","article-title":"Platelets in myocardial ischemia\/reperfusion injury","volume":"43","author":"Schanze","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2024.04.026_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MOH.0000000000000237","article-title":"Extracellular matrix proteins in the regulation of thrombus formation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1538-7836.2005.01217.x","article-title":"Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation","volume":"3","author":"Reheman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.026_bb0060","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2005-10-4168","article-title":"Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi","volume":"107","author":"Cho","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.04.026_bb0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.ATV.0000216282.58291.c6","article-title":"Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles","volume":"26","author":"Matuskova","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0070","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1878-0261.12705","article-title":"Human fibronectin extra domain B as a biomarker for targeted therapy in cancer","volume":"14","author":"Lieverse","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/14728222.9.3.491","article-title":"ED-B fibronectin as a target for antibody-based cancer treatments","volume":"9","author":"Menrad","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.thromres.2024.04.026_bb0080","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00005537-200307000-00023","article-title":"Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors","volume":"113","author":"Birchler","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.thromres.2024.04.026_bb0085","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2014-10-608653","article-title":"Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4","volume":"125","author":"Prakash","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.04.026_bb0090","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1055\/s-0038-1661353","article-title":"Deletion of extra domain A of fibronectin reduces acute myocardial ischemia\/reperfusion injury in hyperlipidemic mice by limiting thrombo-inflammation","volume":"118","author":"Chorawala","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.026_bb0095","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/jth.15206","article-title":"Cellular fibronectin promotes deep vein thrombosis in diet-induced obese mice","volume":"19","author":"Dhanesha","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.026_bb0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood.2019002846","article-title":"Targeting myeloid-cell specific integrin \u03b19\u03b21 inhibits arterial thrombosis in mice","volume":"135","author":"Dhanesha","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.04.026_bb0105","doi-asserted-by":"crossref","first-page":"21935","DOI":"10.1016\/S0021-9258(18)45828-0","article-title":"Effect of hypertension on fibronectin expression in the rat aorta","volume":"265","author":"Takasaki","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2024.04.026_bb0110","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/ATVBAHA.115.306474","article-title":"Fibronectin splicing variants containing extra domain A promote atherosclerosis in mice through Toll-like receptor 4","volume":"35","author":"Doddapattar","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0115","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1161\/CIRCULATIONAHA.115.016540","article-title":"Genetic ablation of extra domain A of fibronectin in hypercholesterolemic mice improves stroke outcome by reducing thrombo-inflammation","volume":"132","author":"Dhanesha","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.04.026_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-4-21","article-title":"Plasma and cellular fibronectin: distinct and independent functions during tissue repair","volume":"4","author":"W.S. To","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.thromres.2024.04.026_bb0125","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1172\/JCI74630","article-title":"Plasma fibronectin supports hemostasis and regulates thrombosis","volume":"124","author":"Wang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.04.026_bb0130","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1073\/pnas.2628067100","article-title":"Plasma fibronectin promotes thrombus growth and stability in injured arterioles","volume":"100","author":"Ni","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.thromres.2024.04.026_bb0135","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2008-04-148361","article-title":"Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor","volume":"113","author":"Reheman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.04.026_bb0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2010.11.007","article-title":"Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis","volume":"127","author":"Prakash","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.04.026_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10557-011-6312-x","article-title":"Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats","volume":"25","author":"Prakash","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.thromres.2024.04.026_bb0150","doi-asserted-by":"crossref","first-page":"17876","DOI":"10.1074\/jbc.274.25.17876","article-title":"Identification of two amino acids within the EIIIA (ED-A) segment of fibronectin constituting the epitope for two function-blocking monoclonal antibodies*","volume":"274","author":"Liao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2024.04.026_bb0155","doi-asserted-by":"crossref","first-page":"28057","DOI":"10.1074\/jbc.M611315200","article-title":"A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived*","volume":"282","author":"Moretti","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2024.04.026_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.200212079","article-title":"Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan","volume":"162","author":"Muro","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0165","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1038\/s41598-020-65970-6","article-title":"Cellular fibronectin containing extra domain A causes insulin resistance via Toll-like receptor 4","volume":"10","author":"Rajak","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2024.04.026_bb0170","doi-asserted-by":"crossref","DOI":"10.3791\/52942-v","article-title":"Cardiac pressure-volume loop analysis using conductance catheters in mice","author":"Abraham","year":"2015","journal-title":"J. Vis. Exp. JoVE"},{"key":"10.1016\/j.thromres.2024.04.026_bb0175","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.116.023003","article-title":"Experimentally increasing titin's compliance through RBM20 inhibition improves diastolic function in a mouse model of HFpEF","volume":"134","author":"Methawasin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.04.026_bb0180","doi-asserted-by":"crossref","DOI":"10.3791\/54479-v","article-title":"Ferric chloride-induced murine thrombosis models","author":"Li","year":"2016","journal-title":"JoVE J. Vis. Exp."},{"key":"10.1016\/j.thromres.2024.04.026_bb0185","first-page":"72","article-title":"Blood volume in the rat","volume":"26","author":"Lee","year":"1985","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.thromres.2024.04.026_bb0190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/ATVBAHA.107.149146","article-title":"Prothrombotic effects of fibronectin isoforms containing the EDA domain","volume":"28","author":"Chauhan","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(94)90201-1","article-title":"Transformed rat arterial smooth muscle cells induce platelet aggregation","volume":"110","author":"Blaes","year":"1994","journal-title":"Atherosclerosis"},{"year":"2012","series-title":"Bancroft's Theory and Practice of Histological Techniques E-Book","author":"Suvarna","key":"10.1016\/j.thromres.2024.04.026_bb0200"},{"key":"10.1016\/j.thromres.2024.04.026_bb0205","first-page":"357","article-title":"Quantification of area percentage of immunohistochemical staining by true color image analysis with application of fixed thresholds","volume":"16","author":"Willemse","year":"1994","journal-title":"Anal. Quant. Cytol. Histol. Int. Acad. Cytol. Am. Soc. Cytol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0218492309102540","article-title":"Off-pump coronary artery bypass in severe left ventricular dysfunction","volume":"17","author":"Pande","year":"2009","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"key":"10.1016\/j.thromres.2024.04.026_bb0215","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1161\/CIRCULATIONAHA.105.566737","article-title":"On-pump and off-pump coronary artery bypass grafting","volume":"113","author":"Shekar","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.04.026_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/021849230000800210","article-title":"Subtotal pericardiectomy via sternotomy for constrictive pericarditis","volume":"8","author":"Srivastava","year":"2000","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"key":"10.1016\/j.thromres.2024.04.026_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/aca.ACA_133_18","article-title":"Statin reload before off-pump coronary artery bypass graft: effect on biomarker release kinetics","volume":"23","author":"Kaushik","year":"2020","journal-title":"Ann. Card. Anaesth."},{"key":"10.1016\/j.thromres.2024.04.026_bb0230","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI12242","article-title":"Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs","volume":"107","author":"Foster","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.04.026_bb0235","doi-asserted-by":"crossref","first-page":"H1366","DOI":"10.1152\/ajpheart.00042.2005","article-title":"15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts","volume":"289","author":"Xia","year":"2005","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1475-2840-12-133","article-title":"Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats","volume":"12","author":"Li","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-2000-8485","article-title":"Loss of myocardial CK-MB into the circulation following 3.5 hours of swimming in a rat model","volume":"21","author":"Chen","year":"2000","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.thromres.2024.04.026_bb0250","first-page":"52","article-title":"[The dynamic change of serum CK, CK-MB and myocardium histomorphology after exhausted exercise in rats], Zhongguo Ying Yong Sheng Li Xue Za Zhi Zhongguo Yingyong Shenglixue Zazhi Chin","volume":"27","author":"Wang","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0255","doi-asserted-by":"crossref","first-page":"H500","DOI":"10.1152\/ajpheart.00381.2014","article-title":"Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy","volume":"308","author":"Ge","year":"2015","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","article-title":"Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury","volume":"61","author":"Vinten-Johansen","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2024.04.026_bb0265","doi-asserted-by":"crossref","first-page":"H93","DOI":"10.1152\/ajpheart.1986.251.1.H93","article-title":"Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia","volume":"251","author":"Engler","year":"1986","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.thromres.2024.04.026_bb0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0037-1613694","article-title":"Thromboinflammatory functions of platelets in ischemia-reperfusion injury and its dysregulation in diabetes","volume":"44","author":"Maiocchi","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2024.04.026_bb0275","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCRESAHA.110.224428","article-title":"Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction","volume":"108","author":"Arslan","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2024.04.026_bb0280","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates toll-like receptor 4 *","volume":"276","author":"Okamura","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2024.04.026_bb0285","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1038\/s41598-022-13622-2","article-title":"Fibronectin containing alternatively spliced extra domain A interacts at the central and c-terminal domain of Toll-like receptor-4","volume":"12","author":"Gupta","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2024.04.026_bb0290","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T08:40:32Z","timestamp":1716021632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":58,"alternative-id":["S0049384824001452"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.026","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}